RAPT - RAPT Therapeutics, Inc.
IEX Last Trade
1.8
0.100 5.556%
Share volume: 33,615
Last Updated: Fri 27 Dec 2024 08:30:24 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.70
0.10
5.88%
Summary score
19%
Profitability
3%
Dept financing
25%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.96%
Return on assets
-15.72%
Return on sales
0%
Return on invested capital
-1903.68%
Total debt ratio
212.74%
Debt ratio change over timeo
-1.19%
Current Ratio
11.71%
Quick Ratio
0%
Cash Position Ratio
12.27%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
1.96%
Return on assets
-15.72%
Return on sales
0%
Return on invested capital
-1903.68%
Total debt ratio
212.74%
Debt ratio change over timeo
-1.19%
Current Ratio
11.71%
Quick Ratio
0%
Cash Position Ratio
12.27%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-18.07%
Return on assets
-15.15%
Return on sales
0%
Return on invested capital
256.12%
Total debt ratio
13.57%
Debt ratio change over time
-1.02%
Current Ratio
8.7%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.57%
Return on assets
-98.09%
Return on sales
0%
Return on invested capital
292.52%
Total debt ratio
-118.52%
Debt ratio change over time
-1.19%
Current Ratio
-2.17%
Quick Ratio
0%
Cash Position Ratio
-1.98%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RAPT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1.96% | 3.38% | 10.1% | 6.09% |
| Return on assets | -15.72% | 3.79% | 3.51% | 5.38% |
| Return on sales | 0% | 33.46% | 42.92% | 33.01% |
| Return on invested capital | -1903.68% | 4.88% | 8.3% | 11.96% |
| Profitability | 5% | 56% | 84% | 84% |
| Total debt ratio | 212.74% | 100.22% | 71.21% | 29.5% |
| Debt ratio change over time | -1.19% | 14.95% | 5.12% | 1.7% |
| Dept financing | 25% | 37% | 17% | 6% |
| Current Ratio | 11.71% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 12.27% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 14% | 34% | 32% |
| Short-term ratios | RAPT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1.96% | -24.18% | 18.55% | 5.09% |
| Return on assets | -15.72% | 4.92% | 3.95% | 4% |
| Return on sales | 0% | 37.6% | 41.32% | 27.89% |
| Return on invested capital | -1903.68% | 7.93% | 10.38% | 10.86% |
| Profitability | 3% | 66% | 94% | 69% |
| Total debt ratio | 212.74% | 112.95% | 82.58% | 25.55% |
| Debt ratio change over time | -1.19% | 16.62% | 5.88% | 2.04% |
| Dept financing | 25% | 38% | 19% | 6% |
| Current Ratio | 11.71% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 12.27% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 16% | 24% | 37% |